Navigation Links
International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease

Results presented at the Movement Disorder Society's 11th International Congress in Istanbul, Turkey

KANSAS CITY, Mo., June 08, 2007 /PRNewswire-FirstCall/ -- New information on the use of AZILECT(R) (rasagiline tablets) for the treatment of Parkinson's disease (PD) was reported this week at The Movement Disorder Society's congress in Istanbul, Turkey. Once-daily AZILECT was approved by the FDA May 17, 2006, for the treatment of the signs and symptoms of PD, both as initial monotherapy and as adjunct therapy to levodopa.

AZILECT(R) Monotherapy Demonstrates Benefits in Early PD Regardless of Disease Duration

Dr. John Bertoni, M.D., Ph.D., provided the results of a new post-hoc analysis of the 26-week, multicenter, randomized, double-blind TEMPO study, that included 404 patients who received once-daily AZILECT 1mg, 2mg, or placebo. This analysis revealed that AZILECT once-daily as monotherapy provided a consistent beneficial effect on the symptoms of PD regardless of the duration of the disease at the time treatment was started. AZILECT 1 mg/day significantly improved UPDRS-Total score compared to placebo in both the < 1-year stratum (-0.52 vs 3.33; p<0.001) and the greater than or equal to 1-year stratum (0.81 vs 4.76; p<0.01). "The time to diagnosis and initial treatment is different for every patient," said Dr. Bertoni. "Demonstrating that AZILECT monotherapy has a beneficial effect, regardless of disease duration, is important when considering it as a treatment option for patients with PD."

AZILECT(R) Clinical Experience When Given Concomitantly with Antidepressants

Dr. Michel Panisset, M.D., CHUM - Hotel-Dieu de Montreal, Quebec, reported on an evaluation of the records of 1,361 patients who had taken AZILECT for the treatment of Parkinson's disease in controlled clinical trials to assess the safety of combining antidepressant therapy with AZILECT. Three hundred and twenty three (
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
7. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
9. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
Post Your Comments:
(Date:8/28/2015)... 2015  Perrigo Company plc ("Perrigo") (NYSE: PRGO ... acquisition of leading OTC brands from GSK in an ... is a clear demonstration of Perrigo,s unique ability to ... network spanning 36 countries.  Perrigo Chairman, ... "We are excited to complete this transaction, which clearly ...
(Date:8/28/2015)... India , August 28, 2015 ... Oils), Livestock (Pork/Swine, Poultry, Ruminant, and Aquaculture), & by Region ... , Asia-Pacific , and Rest of the ... MarketsandMarkets, The global market for Eubiotics was valued at USD ... 7.05 Billion by 2020, at a CAGR of 7.4% from ...
(Date:8/27/2015)... 27, 2015  The Academy of Managed Care ... Administration,s (FDA,s) draft guidance and proposed rule that ... to bear a nonproprietary name with an FDA-designated ... a decision from the FDA on the naming ... stakeholders urging the agency to use the same ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2
... NANJING, China, Oct. 29 /PRNewswire-Asia/ ... or the "Company"), a leading pharmaceutical company,specializing in ... proprietary pharmaceuticals in China, today announced that it ... stake in ChinaVax, a Cayman,Islands company that, as ...
... Biotech, LLC, a corporation based in Hopkinton, Massachusetts, and ... its current sales managers, William Heppner of Illinois, David ... were charged today in federal court with participating in ... invasive spinal and long bone surgeries. Stryker Biotech and ...
Cached Medicine Technology:Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. 2Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. 3Stryker Biotech and its Top Management Indicted for Illegal Promotion of Medical Devices Used in Invasive Surgeries 2Stryker Biotech and its Top Management Indicted for Illegal Promotion of Medical Devices Used in Invasive Surgeries 3
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... reviews of the top 5 millionaire dating sites . According to the ... as the second best in this category. , A spokesperson of Top5MillionaireDatingSites.com ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Plaintiffs ... as MDL 2545, Testosterone Replacement Therapy Products Liability Litigation, are in the midst ... custodial files the PSC may receive for corporate employees involved in the production ...
(Date:8/28/2015)... ... August 28, 2015 , ... A complimentary webinar offered ... Medicare & Medicaid Services’ (CMS) proposal to mandate bundled payments through the ... “Get Ready for Game Day: Comprehensive Care for Joint Replacement,” takes place at 12 ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... Super-Sod launched ... new look and updated navigation. The most notable change is the responsive web design. ... other smart devices. Customers can easily submit quote requests for sod, sign-up for the ...
(Date:8/28/2015)... ... 28, 2015 , ... Where can successful, well educated, or ... set up to help quality singles find dating partners or ideal matches. , ... gorgeous, well educated, or attractive. , It updates profiles under the category of ...
Breaking Medicine News(10 mins):Health News:Top5MillionaireDatingSites.com Publishes Its First List of Reviews of the Best Millionaire Dating Sites 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 2Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 3
... Two studies that offer new insights to help ... be presented by researchers from Cincinnati Childrens Hospital Medical ... Academic Society (PAS) in Honolulu, Hawaii. , One study, ... asthma dramatically overestimate their ability to control the condition, ...
... Misys plc (FTSE: MSY.L), the,global application software and services ... solutions have been selected by Masraf Al,Rayan to build ... Misys was chosen as the best partner for ... of its proven expertise in Islamic,finance and credibility in ...
... clipping a,pet parrots wings so that it can,t fly in ... pet birds then many people realize, and be,a violation of ... psychological problems as a,direct result from having their God given ... This lack of physical ability to fly and exercise ...
... Integrium, LLC(R), a,cardiovascular and metabolic focused clinical ... results, has officially launched,Integrium Clinical Excellence (ICE), a ... results on time and on,budget in all of ... is a,series of steps that provide a high ...
... 10 Percent Cuts from Taking,Effect July 1; Providers Say ... Calif., May 5 In an effort to,ensure that ... a coalition of health care providers today filed a ... 10 percent cut in,Medi-Cal and Denti-Cal payments from taking ...
... Natural Nutrition,Inc. (OTC Bulletin Board: NTNI) announced today that ... 2008 at 9 PM ET to discuss the upcoming ... iNutrition CEO Tim Connolly said, "iNutrition.com is all ... the very latest sports,lifestyle, and nutrition secrets for a ...
Cached Medicine News:Health News:Teens think they have asthma under control, but benefit from new approach to treatment 2Health News:Misys Facilitates Masraf Al Rayan's Expansion of Islamic Banking Operations 2Health News:Misys Facilitates Masraf Al Rayan's Expansion of Islamic Banking Operations 3Health News:How Clipping Pet Parrot's Wings May Violate Their Animal Rights 2Health News:Integrium Introduces Its Integrium Clinical Excellence (ICE) Methodology to Assure Consistent Delivery of Sponsor Clinical Trials 2Health News:Integrium Introduces Its Integrium Clinical Excellence (ICE) Methodology to Assure Consistent Delivery of Sponsor Clinical Trials 3Health News:Integrium Introduces Its Integrium Clinical Excellence (ICE) Methodology to Assure Consistent Delivery of Sponsor Clinical Trials 4Health News:Health Care Providers Sue State of California Over Cuts in Medi-Cal Payments 2Health News:Health Care Providers Sue State of California Over Cuts in Medi-Cal Payments 3Health News:Health Care Providers Sue State of California Over Cuts in Medi-Cal Payments 4Health News:Health Care Providers Sue State of California Over Cuts in Medi-Cal Payments 5Health News:Natural Nutrition to Hold Conference Call on Launch of iNutrition.com 2
... The Precision PCx point of ... a whole-blood, patient-side testing system for ... use, the system provides fast, accurate ... hospital and laboratory information systems enables ...
... Analyzer (PCA) is used in conjunction ... a variety of parameters in whole ... 50 patient records and permits on-screen ... as transmission of records to a ...
... left-heart lead is for use with cardiac ... an angled shape and can be inserted ... delivery method, giving physicians an extra option ... in a variety of difficult venous anatomies. ...
Ideal for use with our High Beam headlight. Rotating Turret allows use with other manufacturer's cables. Infinite intensity control. Excellent color definition (6000 K Color Temperature)....
Medicine Products: